These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 22375069
21. Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat. Bohra R, Schöning W, Klawitter J, Brunner N, Schmitz V, Shokati T, Lawrence R, Arbelaez MF, Schniedewind B, Christians U, Klawitter J. PLoS One; 2012; 7(10):e48063. PubMed ID: 23118926 [Abstract] [Full Text] [Related]
23. Pharmacodynamic approach to immunosuppressive therapies using calcineurin inhibitors and mycophenolate mofetil. Millán O, Brunet M, Campistol JM, Faura A, Rojo I, Vidal E, Jiménez O, Vives J, Oppenheimer F, Martorell J. Clin Chem; 2003 Nov; 49(11):1891-9. PubMed ID: 14578321 [Abstract] [Full Text] [Related]
25. Drug interaction between cyclosporine and mTOR inhibitors in experimental model of chronic cyclosporine nephrotoxicity and pancreatic islet dysfunction. Piao SG, Bae SK, Lim SW, Song JH, Chung BH, Choi BS, Yang CW. Transplantation; 2012 Feb 27; 93(4):383-9. PubMed ID: 22267156 [Abstract] [Full Text] [Related]
26. Relative tissue distributions of cyclosporine and sirolimus after concomitant peroral administration to the rat: evidence for pharmacokinetic interactions. Napoli KL, Wang ME, Stepkowski SM, Kahan BD. Ther Drug Monit; 1998 Apr 27; 20(2):123-33. PubMed ID: 9558125 [Abstract] [Full Text] [Related]
30. Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients. Barten MJ, Rahmel A, Garbade J, Bold A, Bittner HB, Dhein S, Mohr FW, Gummert JF. Transplant Proc; 2005 Dec 27; 37(10):4532-4. PubMed ID: 16387162 [Abstract] [Full Text] [Related]
31. Prospective comparison of the use of sirolimus and cyclosporine in recipients of a kidney from an expanded criteria donor. Durrbach A, Rostaing L, Tricot L, Ouali N, Wolf P, Pouteil-Noble C, Kessler M, Viron B, Thervet E. Transplantation; 2008 Feb 15; 85(3):486-90. PubMed ID: 18301342 [Abstract] [Full Text] [Related]
32. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination. Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP, Sirolimus Renal Function Study Group. Transplantation; 2002 Dec 15; 74(11):1560-7. PubMed ID: 12490789 [Abstract] [Full Text] [Related]
38. Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis. Duncan FJ, Wulff BC, Tober KL, Ferketich AK, Martin J, Thomas-Ahner JM, Allen SD, Kusewitt DF, Oberyszyn TM, Vanbuskirk AM. Am J Transplant; 2007 Dec 15; 7(12):2693-703. PubMed ID: 17941958 [Abstract] [Full Text] [Related]
39. TGF-β1 mediates sirolimus and cyclosporine A-induced alteration of barrier function in renal epithelial cells via a noncanonical ERK1/2 signaling pathway. Martin-Martin N, Slattery C, McMorrow T, Ryan MP. Am J Physiol Renal Physiol; 2011 Dec 15; 301(6):F1281-92. PubMed ID: 21880834 [Abstract] [Full Text] [Related]